UK markets closed

Unity Biotechnology, Inc. (UBX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.43-0.23 (-2.16%)
At close: 4:00PM EDT
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
0
0
0
1,382
0
Operating expenses
Research development
71,372
70,957
58,907
37,373
13,707
Selling general and administrative
22,872
20,046
16,016
9,617
5,137
Total operating expenses
92,892
89,651
74,923
46,990
18,844
Operating income or loss
-92,892
-89,651
-74,923
-45,608
-18,844
Total other income/expenses net
4,200
4,185
-4,787
-103
-9,377
Income before tax
-86,442
-82,177
-76,398
-44,656
-30,404
Income from continuing operations
-86,442
-82,177
-76,398
-44,656
-30,404
Net income
-86,442
-82,177
-76,398
-44,656
-30,404
Net income available to common shareholders
-86,442
-82,177
-76,398
-44,656
-30,404
Basic EPS
-
-1.88
-2.70
-1.49
-8.85
Diluted EPS
-
-1.88
-2.70
-1.49
-8.85
Basic average shares
-
43,625
28,270
30,039
3,437
Diluted average shares
-
43,625
28,270
30,039
3,437
EBITDA
-
-86,988
-72,743
-44,304
-18,691
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more